Search
for
Sort by
Research 30 of 702
- Development of the CLASI as an outcome instrument for cutaneous lupus erythematosus
- Validation of the Cutaneous Lupus Disease Area and Severity Index (CLASI) using physician- and patient-assessed health outcome measures
- Evaluation of disease activity and damage in different subtypes of cutaneous lupus erythematosus using the CLASI
- All Subcomponents of the Cutaneous Lupus Erythematosus Disease Area and Severity Index–Activity (CLASI-A) are Relevant to Identify and Detect Changes in Skin Activity
- LO-009 Responsiveness of the CLASI to alopecia and mucous membrane involvement: a retrospective study of prospectively collected data
- CZY W NAJBLIŻSZYM CZASIE MOGĄ POPRAWIĆ SIĘ WYNIKI LECZENIA GLEJAKÓW?
- Actualización terapéutica en corticoesteroides tópicos: clasificación, usos clínicos y efectos colaterales
- Tratamiento ortobiológico con plasma rico en plaquetas. Revisión sistemática y clasificación de la evidencia
- A Clinical Genetics-Driven Dual Diagnosis of Prader–Willi Syndrome Due to Mosaic Maternal UPD(15) and NOTCH3-Related CADASIL
- Tratamiento de la alopecia areata, un recorrido desde las opciones terapéuticas clásicas hasta los nuevos fármacos aparecidos en los últimos años
- DP10 Scalp disease in dermatomyositis
- 570 Examining cutaneous disease activity as an outcome measure for clinical trials in dermatomyositis
- 341 A longitudinal study of cutaneous dermatomyositis
- Overview of common, rare and atypical manifestations of cutaneous lupus erythematosus and histopathological correlates
- Development of a Core Set Questionnaire by the European Society of Cutaneous Lupus Erythematosus (EUSCLE)
- Evaluation of the quality of life of lupus erythematosus patients with cutaneous lesions in Japan
- Discoid lupus erythematosus skin lesion distribution and characteristics in Black patients: a retrospective cohort study
- A Wnt5a-Cdc42 axis controls aging and rejuvenation of hair-follicle stem cells
- Skin
- Outcome Measures in Cutaneous Autoimmune Disease: Dermatomyositis and Lupus Erythematosus
- POS0548 ACUTE AND SUBACUTE SKIN MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS ARE ASSOCIATED WITH AN EARLIER RESPONSE TO BELIMUMAB THAN THE CHRONIC PHENOTYPE: PRELIMINARY DATA FROM THE NEW NATION-WIDE COHORT OF BELIMUMAB IN REAL LIFE SETTING STUDY—NEW JOINT AND SKIN (BERLISS-NEJS)
- Skin involvement in systemic lupus erythematosus: a review article
- A Wnt5a-Cdc42 axis controls aging and rejuvenation of hair-follicle stem cells
- Clinical and Molecular Genetic Findings of Cerebral Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
- Evaluation of trichodynia (hair pain) during chemotherapy or tamoxifen treatment in breast cancer patients
- Digital health platforms expand access and improve care for male androgenetic alopecia
- Anaesthetics and platelets.
- Frontal fibrosing alopecia: Regrowth following cessation of sunscreen on the forehead
- Fluoride Tooth Paste: A Cause of Perioral Dermatitis
- COVID-19: How Effective Are the Repurposed Drugs and Novel Agents in Treating the Infection?